A vulnerability was identified in Grit42 Grit up to 0.11.0. This issue affects the function Grit::Assays::DataTableEntity of the file modules/assays/backend/app/models/grit/assays/data_table_entity.rb. The manipulation leads to sql injection. The attack is possible to be carried out remotely. The exploit is publicly available and might be used. The vendor was contacted early about …

A vulnerability was detected in Grit42 Grit up to 0.11.0. Affected by this issue is some unknown functionality of the file modules/core/backend/app/controllers/concerns/grit/core/grit_entity_controller.rb of the component GritEntityController. Performing a manipulation results in sql injection. The attack may be initiated remotely. The exploit is now public and may be used. The vendor …

This ECHA science seminar features Dr. Thomas Steger-Hartmann an investigational toxicologist in the pharmaceutical industry and industry leader of the IHI VICT3R consortium, which strives to implement virtual control groups (VCGs) in preclinical safety studies. Claus Stie Kallesøe is an expert in research informatics and data management representing grit42, the partner who develops the central repository for VCGs. Their presentation covers an introduction into the concept of VCGsvirtual control groups with an overview on the regulatory qualification strategy and a case study. Who should attend? This session is useful for professionals in human health hazard and risk assessment and researchers working with historical control data from animal studies. What you will gain By the end of the seminar, you will: • Understand the concept of virtual control groups • Learn about the status of regulatory acceptance • Gain clearer insight into the VICT3R database and how it may also serve for retrieval of historical control data More: https://echa.europa.eu/science/discussions-and-seminars ************** Subscribe to our channel: https://bit.ly/321VQgE Subscribe to our Safer Chemicals Podcast: https://echa.europa.eu/podcasts Subscribe to our news: https://echa.europa.eu/subscribe Follow us on: *LinkedIn: https://www.linkedin.com/company/european-chemicals-agency *X: https://x.com/EU_ECHA *BlueSky: https://bsky.app/profile/echa.europa.eu *Facebook: https://www.facebook.com/EUECHA/ *Instagram: https://www.instagram.com/onehealth_eu/ Visit our website: https://echa.europa.eu/ Disclaimer: Views expressed by interviewees do not necessarily represent the official position of the European Chemicals Agency. All content is up to date at the time of publication. Disclaimer: Subtitles are generated by YouTube automatically. The subtitles are made available “as is” without any additional check by ECHA or a third party as to their accuracy or linguistic correctness. ECHA does not guarantee that the subtitles correctly reflect what is being said in the video. The subtitles may be subject to inaccuracies or misrepresentation due to the inherent limitations of the algorithms used. ECHA accepts no liability in connection with the use of the subtitles. You agree to use the subtitles at your own risk and shall not hold ECHA responsible for damage you or any third party may suffer in connection to their use.

This ECHA science seminar features Dr. Thomas Steger-Hartmann an investigational toxicologist in the pharmaceutical industry and industry leader of the IHI VICT3R consortium, which strives to implement virtual control groups (VCGs) in preclinical safety studies. Claus Stie Kallesøe is an expert in research informatics and data management representing grit42, the partner who develops the central repository for VCGs. Their presentation covers an introduction into the concept of VCGsvirtual control groups with an overview on the regulatory qualification strategy and a case study. Who should attend? This session is useful for professionals in human health hazard and risk assessment and researchers working with historical control data from animal studies. What you will gain By the end of the seminar, you will: • Understand the concept of virtual control groups • Learn about the status of regulatory acceptance • Gain clearer insight into the VICT3R database and how it may also serve for retrieval of historical control data More: https://echa.europa.eu/science/discussions-and-seminars ************** Subscribe to our channel: https://bit.ly/321VQgE Subscribe to our Safer Chemicals Podcast: https://echa.europa.eu/podcasts Subscribe to our news: https://echa.europa.eu/subscribe Follow us on: *LinkedIn: https://www.linkedin.com/company/european-chemicals-agency *X: https://x.com/EU_ECHA *BlueSky: https://bsky.app/profile/echa.europa.eu *Facebook: https://www.facebook.com/EUECHA/ *Instagram: https://www.instagram.com/onehealth_eu/ Visit our website: https://echa.europa.eu/ Disclaimer: Views expressed by interviewees do not necessarily represent the official position of the European Chemicals Agency. All content is up to date at the time of publication. Disclaimer: Subtitles are generated by YouTube automatically. The subtitles are made available “as is” without any additional check by ECHA or a third party as to their accuracy or linguistic correctness. ECHA does not guarantee that the subtitles correctly reflect what is being said in the video. The subtitles may be subject to inaccuracies or misrepresentation due to the inherent limitations of the algorithms used. ECHA accepts no liability in connection with the use of the subtitles. You agree to use the subtitles at your own risk and shall not hold ECHA responsible for damage you or any third party may suffer in connection to their use.